Thin-layer identification method for allium macrostemon and method for distinguishing allium macrostemon from counterfeit allium macrostemon

By using methanol and n-butanol extraction and washing methods, combined with thin-layer plate expander of trichloromethane-ethyl acetate-methanol-water, the problem of insufficient fat-soluble components in thin layers of ceram-formula formula particles was solved, and rapid , simple identification of scallions and fake tastes improves separation and simplicity of operation, and is suitable for actual production.

CN119023873AActive Publication Date: 2024-11-26JIANGYIN TIANJIANG PHARMA

Patent Information

Application Number
CN202411133956.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-19
Publication Date
2024-11-26
Estimated Expiration
2044-08-19

AI Technical Summary

Technical Problem

The prior art is difficult to quickly, easily and at low cost to identify the pellets of leucorrhea formula, especially because of their few fat-soluble components, resulting in few spots, unclear, poor separation, and complicated process of passing the column. The high operating requirements limit their application in actual production.

Method used

The n-butanol solution saturated with methanol and water was used for shaking extraction, combined with the ammonia test solution and the saturated aqueous solution of n-butanol, prepare the test solution and the control medicinal solution, and use trichloromethane-ethyl acetate-methanol-water To spot the spreader on the thin-layer plate, the use of sunlight and ultraviolet lights was used to simplify the processing process and improve the resolution.

Benefits of technology

It realizes rapid and simple identification of scallions and their counterfeit products, improves the specificity of the method, reduces the complexity of the operation, is suitable for actual production, and does not require tedious column-passing steps, significantly improving detection efficiency and accuracy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119023873A_ABST
    Figure CN119023873A_ABST
Patent Text Reader

Abstract

The invention discloses a thin-layer identification method for allium macrostemon, which is a method for distinguishing allium macrostemon from counterfeit allium macrostemon. The method comprises the following steps: preparing a test solution and a reference medicinal material solution; respectively applying samples on the same thin-layer plate, spreading, taking out, airing, spraying a sulfuric acid ethanol solution, heating until spots are clearly developed, and respectively inspecting under sunlight and ultraviolet lamps; when a main spot or a fluorescent main spot with the same color appears at a position corresponding to the color spectrum of the reference medicinal material in the color spectrum of the to-be-tested sample, the to-be-tested sample is the allium macrostemon. According to the invention, the problem that a pharmacopoeia method is not applicable due to less fat-soluble components in the allium macrostemon formula granules is solved; a sample is treated by a simple treatment method, and is inspected under sunlight and an ultraviolet lamp at the same time, the number of spots is large, the separation degree is relatively good, various components in the sample can be detected, and the specificity of the method is greatly improved; the method can be used for easily distinguishing allium macrostemon and counterfeit Chinese squill and fire onion, and has great practical value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a thin-layer identification method for Xiebai and a method for distinguishing Xiebai from counterfeit products, and belongs to the field of thin-layer identification of Xiebai. Background Art

[0002] Xiebai is the dried bulb of Allium macrostemon Bge. or Allium chinense G.Don, a plant of the Liliaceae family. It is dug up in summer and autumn, cleaned, the fibrous roots are removed, steamed or boiled in boiling water, and dried. Xiebai is mainly produced in Northeast China, Hebei, Jiangsu, Hubei and other places, and is distributed in most parts of the country. Xiebai contains rich medicinal ingredients, including saponins, volatile oils, acidic substances, nitrogen-containing compounds, etc.

[0003] Chinese medicine formula granules are a breakthrough in the application of traditional Chinese medicine slices. They are usually made from slices of Chinese medicine, and are extracted (usually mainly with water), concentrated, dried and granulated. Their nature, flavor, meridians and efficacy are basically the same as the original slices. They also have the advantages of no need for decoction, easy adjustment, storage and convenient use, and are gradually being widely used. In the 2020 edition of the Chinese Pharmacopoeia, there is only a thin layer identification item for Xiebai medicinal materials, and there is currently no corresponding quality control standard for Xiebai formula granules.

[0004] Most of the literature adopts the pharmacopoeia method, using n-hexane as the extraction solvent to perform thin layer identification on Xiebai medicinal materials, decoction pieces, granules, etc.; some literature uses n-butanol as the extraction solvent, and then purifies the sample through multiple column passes to extract the water-soluble components. However, after water extraction, the fat-soluble components of Chinese medicine granules are relatively small. If the pharmacopoeia method is directly used, there will be problems such as few spots, unclearness, and poor separation. The column pass process is relatively complicated. Although the literature can effectively purify the sample through multiple column passes, its preparation process is too cumbersome and has high requirements for operators, which is not conducive to its application in actual production.

[0005] The patent application (a method for processing water-soluble components in Xiebai, a thin-layer identification method, and the application of a developing agent, application number: 2022106862707) uses n-butanol as an extraction solvent, and then purifies the sample through multiple column passes to extract the water-soluble components. The column pass process is relatively complicated. Although the sample can be effectively purified after multiple column passes, its preparation process is too cumbersome and has high requirements for operators, which is not conducive to its application in actual production.

[0006] Therefore, it is an important topic to establish a rapid, simple and low-cost thin layer identification method for Xiebai formula granules. Summary of the invention

[0007] Purpose of the invention: The technical problem to be solved by the present invention is to provide a thin layer identification method for Xiebai and a method for distinguishing Xiebai from counterfeit products.

[0008] Technical solution: To solve the above technical problems, the present invention provides a thin layer identification method of Xiebai, comprising the following steps:

[0009] (1) Prepare the test solution: take the test sample powder, add methanol, ultrasonically treat, filter, evaporate the filtrate to dryness, dissolve the residue in water, shake and extract with a saturated n-butanol solution with water, combine the n-butanol solution, wash with an ammonia test solution, discard the ammonia test solution, wash with a saturated n-butanol aqueous solution, discard the water solution, evaporate the n-butanol solution to dryness, dissolve the residue in methanol, and use it as the test sample solution;

[0010] (2) Preparation of Xiebai control solution: Take Xiebai control medicinal material, add water, heat to reflux, cool, filter, concentrate the filtrate to near dryness, add methanol to the residue, ultrasonicate, filter, evaporate the filtrate to dryness, dissolve the residue in water, shake and extract with a saturated n-butanol solution, combine the n-butanol solution, wash with ammonia test solution, discard the ammonia test solution, wash with a saturated n-butanol aqueous solution, discard the water solution, evaporate the n-butanol solution to dryness, dissolve the residue in methanol, and use it as the control medicinal material solution;

[0011] (3) Spot the test sample solution and the Xiebai control solution on the same thin layer plate, develop with chloroform-ethyl acetate-methanol-water as the developing solvent, take out, dry, spray with 10% sulfuric acid ethanol solution, heat at 105°C until the spots are clearly colored, and examine under sunlight and ultraviolet light respectively;

[0012] (4) When a main spot or a fluorescent main spot of the same color appears in the chromatogram of the test sample at the corresponding position in the chromatogram of the reference medicinal material, the test sample is Xiebai.

[0013] Wherein, the spotting volume of the test sample in step (3) is 5 to 15 μl.

[0014] Wherein, the spotting volume of the Xiebai control solution in step (3) is 5 to 15 μl.

[0015] Wherein, the development temperature in step (3) is 10-40°C.

[0016] Wherein, the humidity of the unfolding in step (3) is 18% to 88%.

[0017] The present invention also provides a method for distinguishing Xiebai from counterfeit products, comprising the following steps:

[0018] (1) preparing a test sample solution and a control solution according to the method;

[0019] (2) Spot the test sample solution and the Xiebai control solution on the same thin layer plate, develop with chloroform-ethyl acetate-methanol-water as the developing solvent, take out, dry, spray with 10% sulfuric acid ethanol solution, heat at 105℃ until the spots are clearly colored, and examine under sunlight and ultraviolet light respectively;

[0020] (3) When the main spot or fluorescent main spot of the same color appears at the corresponding position in the chromatogram of the test sample and the control medicinal material, the test sample is Xiebai. Otherwise, it is a counterfeit.

[0021] Wherein, the spotting volume of the test sample in step (2) is 5 to 15 μl.

[0022] Wherein, the spotting volume of the Xiebai control solution in step (2) is 5 to 15 μl.

[0023] Wherein, the development temperature in step (2) is 10-40°C.

[0024] Wherein, the humidity of the unfolding in step (2) is 18% to 88%.

[0025] Among them, the thin layer plate described in step (2) includes silica gel H thin layer plate, silica gel G thin layer plate, high-efficiency silica gel G thin layer plate, silica gel GF254 thin layer plate, silica gel HF254 thin layer plate, and high-efficiency silica gel H thin layer plate.

[0026] The sample processing methods and developing agent compositions disclosed in the article (Research on the Quality Standard of Guaxie Jiangzhi Drop Pills, Zheng Ji, Wang Hui, Sun Zhiqiang, Dai Long, Liaoning Journal of Traditional Chinese Medicine, Vol. 39, No. 9, 2012) and the patent (A Thin Layer Identification Method for Xiebai Samples, Application No.: 202110735282X) are quite different from those of this method, and the determined components are also different from those of this method. The main extracted components using ethyl acetate as the extraction solvent are fat-soluble components, while this method mainly determines water-soluble components. Therefore, they are not of reference significance for this method.

[0027] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages: 1. It solves the problem that the pharmacopoeia method is not applicable due to the small amount of fat-soluble components in the Xiebai formula granules; 2. A control medicinal material is used as a control substance, and the sample is treated with a simple treatment method, and is inspected under sunlight and ultraviolet light (365nm) at the same time. The number of spots is large and the separation is good, and multiple components in the sample can be detected, which greatly improves the specificity of the method; Xiebai and its counterfeits such as schizonepeta tenuifolia and shallot can be easily distinguished by this method, which has great practical value; 3. The present invention uses n-butanol for shaking extraction and uses ammonia test solution for washing. While effectively extracting its water-soluble components, the impurity components therein are removed to the greatest extent; 4. The method of the present invention is simple to operate, eliminates the cumbersome column passing steps, has low requirements for experimental personnel, and has high application value in actual production. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1 The TLC spectra of Xiebai formula granules prepared by different methods: A: TLC spectrum under sunlight, B: TLC spectrum under ultraviolet light;

[0029] Figure 2 The TLC spectra of Xiebai formula granules under different sample loadings are shown below: A: TLC spectra under sunlight, B: TLC spectra under ultraviolet light;

[0030] Figure 3 To investigate the specificity of Xiebai formula granules: A: TLC spectrum under sunlight, B: TLC spectrum under ultraviolet light;

[0031] Figure 4 The TLC spectra of Xiebai formula granules under different temperature conditions: A: TLC spectrum at 40℃ and sunlight, B: TLC spectrum at 40℃ and ultraviolet light; C: TLC spectrum at 10℃ and sunlight, D: TLC spectrum at 10℃ and ultraviolet light;

[0032] Figure 5 The TLC spectra of Xiebai formula granules under different humidity conditions: A: TLC spectrum under 18% humidity and sunlight, B: TLC spectrum under 18% humidity and ultraviolet light; C: TLC spectrum under 88% humidity and sunlight, D: TLC spectrum under 88% humidity and ultraviolet light;

[0033] Figure 6 The thin layer identification chromatograms of different batches of Xiebai formula granules: A: TLC spectrum under sunlight, B: TLC spectrum under ultraviolet light;

[0034] Figure 7 The thin layer identification chromatograms of Xiebai formula granules, Mianzaoer formula granules and Huoshang formula granules are shown as follows: A: TLC spectrum under sunlight, B: TLC spectrum under ultraviolet light;

[0035] Figure 8 This is the thin layer identification chromatogram of Xiebai formula granules obtained by the pharmacopoeia method. DETAILED DESCRIPTION

[0036] The technical solution of the present invention is further described below in conjunction with the accompanying drawings.

[0037] Instruments and reagents:

[0038] Instruments: CAMAG TLC VISUALIZER, METTLERTOLEDO, KQ-250E ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.), silica gel H thin layer plate (Qingdao Ocean Chemical Co., Ltd.).

[0039] Test drugs: methanol (Sinopharm Chemical Reagent Co., Ltd.), n-butanol (Sinopharm Chemical Reagent Co., Ltd.), ammonia (Sinopharm Chemical Reagent Co., Ltd.), ethyl acetate (Sinopharm Chemical Reagent Co., Ltd.), chloroform (Shanghai Lingfeng Chemical Reagent Co., Ltd.), sulfuric acid (Shanghai Lingfeng Chemical Reagent Co., Ltd.) are all analytical grade, water; Xiebai control medicinal materials (batch number: 121130-202108) were purchased from the China Food and Drug Inspection Institute. Xiebai formula granules (batch numbers: 20090049, 20090059, 20090069), negative samples lacking Xiebai (auxiliary materials in the granulation process), Mianzaor formula granules, and shallot formula granules were provided by Jiangyin Tianjiang Pharmaceutical Co., Ltd. Among them, Xiebai formula granules and Xiebai control medicinal materials all meet the relevant provisions of the 2020 edition of the Chinese Pharmacopoeia.

[0040] Example 1 Investigation of the preparation methods of the test solution and the control medicinal material solution

[0041] 1. Thin layer identification conditions

[0042] A silica gel H thin layer plate was used with chloroform-ethyl acetate-methanol-water (15:40:22:10) as the developing agent. The plate was developed, taken out, air-dried, sprayed with 10% sulfuric acid ethanol solution, heated at 105°C until the spots were clearly colored, and examined under sunlight and ultraviolet light (365nm).

[0043] 2. Solution preparation

[0044] (1) Preparation of test solution

[0045] Method 1: Take 1 g of Xiebai formula granules (batch number: 20090049), grind it into powder, add 25 ml of methanol, ultrasonically treat it for 30 minutes, filter it, evaporate the filtrate to dryness, add 1 mL of methanol to the residue to dissolve it, and use it as the test solution.

[0046] Method 2: Take 1g of Xiebai formula granules (batch number: 20090049), grind it into powder, add 10ml of water to dissolve it, shake and extract it twice with a water-saturated n-butanol solution, 10ml each time, combine the n-butanol solution, evaporate to dryness, add 1ml of methanol to the residue to dissolve it, and use it as the test solution.

[0047] Method 3: Take 1g of Xiebai formula granules (batch number: 20090049), grind it into powder, add 25ml of methanol, ultrasonically treat it for 30 minutes, filter, evaporate the filtrate to dryness, add 10ml of water to the residue to dissolve it, shake and extract it twice with a water-saturated n-butanol solution, 10ml each time, combine the n-butanol solution, wash it with 20ml of ammonia test solution, discard the ammonia test solution, wash it with 20ml of a saturated n-butanol aqueous solution, discard the water solution, evaporate the n-butanol solution to dryness, add 0.5ml of methanol to the residue to dissolve it, and use it as the test solution.

[0048] (2) Preparation of control medicinal material solution

[0049] Method 1: Take 2g of Xiebai control medicinal material, add 25ml of water, heat and reflux for 30 minutes, cool, filter, concentrate the filtrate to near dryness, add 25ml of methanol to the residue, ultrasonically treat for 30 minutes, filter, evaporate the filtrate to dryness, add 10ml of water to the residue to dissolve it, shake and extract with a saturated n-butanol solution with water twice, 10ml each time, combine the n-butanol solution, wash with 20ml of ammonia test solution, discard the ammonia test solution, and then wash with 20ml of a saturated n-butanol aqueous solution, discard the water solution, evaporate the n-butanol solution to dryness, add 0.5ml of methanol to the residue to dissolve it, as the control medicinal material solution.

[0050] Method 2: Take 2g of Xiebai control medicinal material, add 25ml of methanol, ultrasonically treat for 30 minutes, filter, evaporate the filtrate, add 10ml of water to the residue to dissolve it, shake and extract twice with a water-saturated n-butanol solution, 10ml each time, combine the n-butanol solution, wash with 20ml of ammonia test solution, discard the ammonia test solution, wash with 20ml of a saturated n-butanol aqueous solution, discard the water solution, evaporate the n-butanol solution to dryness, add 0.5ml of methanol to the residue to dissolve it, and use it as the control medicinal material solution.

[0051] (3) Preparation of negative control solution

[0052] Take 1g of the negative sample lacking Allium macrostemon, grind it into powder, add 25ml of methanol, ultrasonically treat it for 30 minutes, filter, evaporate the filtrate to dryness, add 10ml of water to the residue to dissolve it, shake and extract it twice with a saturated n-butanol solution with water, 10ml each time, combine the n-butanol solutions, wash with 20ml of ammonia test solution, discard the ammonia test solution, wash with 20ml of a saturated n-butanol aqueous solution, discard the water solution, evaporate the n-butanol solution to dryness, add 0.5ml of methanol to the residue to dissolve it, and use it as the negative control solution.

[0053] 3. Investigation of the preparation methods of test solution and control medicinal material solution

[0054] Take Xiebai formula granule sample (batch number: 20090049) and Xiebai control medicinal material according to the above three test solution preparation methods and two control medicinal material solution preparation methods, and spot 10μl of the test solution and control medicinal material solution on the same silica gel H thin layer plate, develop at 28.5℃ and 55% humidity, take out, dry, spray with 10% sulfuric acid ethanol solution, heat at 105℃ until the spots are clearly colored, and examine under sunlight and ultraviolet light (365nm). Figure 1 It can be seen that the test solution prepared by method three has clear spots and good separation effect, so method three is selected as the sample processing method for this thin layer identification; Xiebai control medicinal material (method one) is more corresponding to the particle spots, so method one is selected as the control medicinal material processing method. Among them, 1: test sample (method one); 2: test sample (method two); 3: test sample (method three); S1: Xiebai control medicinal material (method one); S2: Xiebai control medicinal material (method two).

[0055] Example 2 Investigation of the influence of different spot amounts on the separation of spots

[0056] Take Xiebai formula granule sample (batch number: 20090049) and Xiebai control medicinal material test solution and control medicinal material solution prepared according to method three of test solution and method one of control medicinal material solution preparation in Example 1, spot them on the same silica gel H thin layer plate according to the thin layer chromatography conditions in Example 1 (the spotting amount of test solution is 2μl, 5μl, 10μl, 15μl respectively; the spotting amount of control medicinal material solution is 2μl, 5μl, 10μl, 15μl respectively), develop at 28.5℃ and 55% humidity, take out, dry, spray with 10% sulfuric acid ethanol solution, heat at 105℃ until the spots are clearly colored, and inspect under sunlight and ultraviolet light (365nm) respectively. Figure 2 It can be seen that when the sample volume of the test solution and the control medicinal material solution is 10μl, the main spots in the test sample chromatogram and the corresponding positions of the control medicinal material chromatogram clearly correspond to each other without other interference, so the sample volume of the test solution and the control medicinal material solution is selected to be 10μl. Among them, 1: 2μl of test sample; 2: 5μl of test sample; 3: 10μl of test sample; 4: 15μl of test sample; 5: 2μl of control medicinal material; 6: 5μl of control medicinal material; 7: 10μl of control medicinal material; 8: 15μl of control medicinal material.

[0057] Example 3 Sample specificity experiment

[0058] Take the Xiebai formula granules test solution (batch number: 20090049) prepared by method 3 of the test solution of Example 1, the negative control solution, and the control medicinal material solution prepared by method 1, and spot 10 μl of each on the same silica gel H thin layer plate according to the thin layer chromatography conditions in Example 1, develop at 28.5°C and 55% humidity, take out, dry, spray with 10% sulfuric acid ethanol solution, heat at 105°C until the spots are clearly colored, and examine under sunlight and ultraviolet light (365nm). Figure 3 It can be seen that the main spots or fluorescent main spots of the same color appear at the corresponding positions of the chromatograms of the Xiebai formula granules and the control medicinal materials, and there is no interference from the negative control, indicating that the thin-layer identification method has good specificity. Among them, 1-3: Xiebai formula granules (20090049); 4: negative control; S: Xiebai control medicinal material.

[0059] Example 4 Investigation of different temperatures

[0060] Take the Xiebai formula granule test solution (batch number: 20090049) prepared by method 3 of the test solution of Example 1 and the control medicinal material solution prepared by method 1 and spot 10μl on the same silica gel H thin layer plate, and develop it under high temperature and low temperature conditions (55% humidity) according to the thin layer chromatography conditions in Example 1, take it out, dry it, spray it with 10% sulfuric acid ethanol solution, heat it at 105℃ until the spots are clearly colored, and examine it under sunlight and ultraviolet light (365nm). Figure 4 It can be seen that under different temperature conditions, the main spots or fluorescent main spots of the same color appear at the corresponding positions of the chromatograms of the Xiebai Formula Granules test sample and the control medicinal material, and the separation effect is good. The experimental results show that temperature has no effect on the thin layer identification of Xiebai Formula Granules, indicating that the thin layer identification method has good durability at different temperatures.

[0061] Example 5 Investigation of different humidity

[0062] Take the Xiebai formula granule test solution (batch number: 20090049) prepared by method 3 of the test solution of Example 1 and the control medicinal material solution prepared by method 1 and spot 10 μl on the same silica gel H thin layer plate, and develop it under different humidity conditions (temperature is 28.5°C) according to the thin layer chromatography conditions in Example 1, take it out, dry it, spray it with 10% sulfuric acid ethanol solution, heat it at 105°C until the spots are clearly colored, and examine it under sunlight and ultraviolet light (365nm). Figure 5 It can be seen that under different humidity conditions, the main spots or fluorescent main spots of the same color appear at the corresponding positions of the chromatograms of the Xiebai formula granules and the control medicinal materials, and the separation effect is good. The experimental results show that humidity has no effect on the thin layer identification of Xiebai formula granules, indicating that the thin layer identification method has good durability under different humidity. Among them, 1-3: Xiebai formula granules (20090049); S: Xiebai control medicinal material.

[0063] According to the above research results, the thin layer identification method of Xiebai formula granules is determined as follows:

[0064] Take 1g of Xiebai formula granules, grind it, add 25ml of methanol, ultrasonically treat it for 30 minutes, filter, evaporate the filtrate to dryness, add 10ml of water to the residue to dissolve it, shake and extract it twice with a water-saturated n-butanol solution, 10ml each time, combine the n-butanol solution, wash it with 20ml of ammonia test solution, discard the ammonia test solution, wash it with 20ml of a saturated n-butanol aqueous solution, discard the water solution, evaporate the n-butanol solution to dryness, add 0.5ml of methanol to the residue to dissolve it, and use it as the test solution. Take another 2g of Xiebai control medicinal material, add 25ml of water, heat and reflux for 30 minutes, cool, filter, concentrate the filtrate to near dryness, add 25ml of methanol to the residue, ultrasonically treat for 30 minutes, filter, evaporate the filtrate to dryness, add 10ml of water to the residue to dissolve it, shake and extract with a saturated n-butanol solution with water twice, 10ml each time, combine the n-butanol solutions, wash with 20ml of ammonia test solution, discard the ammonia test solution, and then wash with 20ml of a saturated n-butanol aqueous solution, discard the water solution, evaporate the n-butanol solution to dryness, add 0.5ml of methanol to the residue to dissolve it, and prepare a control medicinal material solution. According to the thin layer chromatography method (Chinese Pharmacopoeia 2020 Edition Part IV General Rules 0502), 10 μl of the above test solution and control medicinal material solution were taken and spotted on the same silica gel H thin layer plate, and chloroform-ethyl acetate-methanol-water (15:40:22:10) was used as the developing agent. After development, the plate was taken out, dried, sprayed with 10% sulfuric acid ethanol solution, heated at 105°C until the spots were clearly colored, and examined under sunlight and ultraviolet light (365nm). In the chromatogram of the test sample, a main spot of the same color or a fluorescent main spot appeared at the corresponding position of the chromatogram of the control medicinal material.

[0065] Example 6 Thin layer identification of different batches of Xiebai formula granules

[0066] Take different batches of Xiebai formula granules (batch number: 20090049, 20090059, 20090069) and prepare the test solution and control medicinal material solution according to the preparation method of the test solution, spot them on the same silica gel H thin layer plate, develop them, take them out, dry them, spray them with 10% sulfuric acid ethanol solution, heat them at 105℃ until the spots are clearly colored, and inspect them under sunlight and ultraviolet light (365nm). Figure 6 It can be seen that the chromatogram of Xiebai Formula Granule and the chromatogram of the reference medicinal material show the same color main spot or fluorescent main spot at the corresponding position. Among them, 1: Xiebai Formula Granule (20090049); 2: Xiebai Formula Granule (20090059); 3: Xiebai Formula Granule (20090069); S: Xiebai reference medicinal material.

[0067] Example 7 Comparison of Xiebai and its counterfeit products

[0068] Take 1g each of Xiebai Formula Granules (Batch No.: 20090049), Mianzaoer Formula Granules, and Shallot Formula Granules, grind them, add 25ml of methanol, ultrasonically treat for 30 minutes, filter, evaporate the filtrate to dryness, add 10ml of water to the residue to dissolve, shake and extract twice with a saturated n-butanol solution with water, 10ml each time, combine the n-butanol solution, wash with 20ml of ammonia test solution, discard the ammonia test solution, and then wash with 20ml of a saturated n-butanol aqueous solution, discard the water solution, evaporate the n-butanol solution to dryness, add 0.5ml of methanol to the residue to dissolve, and use it as the test solution. Take another 2g of Xiebai control medicinal material, add 25ml of water, heat and reflux for 30 minutes, cool, filter, concentrate the filtrate to near dryness, add 25ml of methanol to the residue, and prepare the control medicinal material solution in the same way. According to the thin layer chromatography method (Chinese Pharmacopoeia 2020 Edition Part IV General Rules 0502), 10 μl of the test solution and the control drug solution were taken and spotted on the same silica gel H thin layer plate, respectively, with chloroform-ethyl acetate-methanol-water (15:40:22:10) as the developing solvent, developed at 25.8°C and 55% humidity, taken out, dried, sprayed with 10% sulfuric acid ethanol solution, heated at 105°C until the spots were clearly colored, and examined under sunlight and ultraviolet light (365nm). From the results, it can be seen that ( Figure 7 ), Xiebai Formula Granules and Mianzaor Formula Granules have obvious differences under ultraviolet light (365nm), Xiebai Formula Granules and Shallot Formula Granules have obvious differences under ultraviolet light (365nm) and sunlight, so this thin layer method can identify Xiebai Formula Granules, Mianzaor Formula Granules, and Shallot Formula Granules. Among them, 1: Xiebai Formula Granules (Batch No.: 20090049, 20090059, 20090069); 4-6: Mianzaor Formula Granules (Batch No.: 2112005, 2112007, 2306031); 7-9: Shallot Formula Granules (Batch No.: 2306032, 2306033, 2306034); S: Xiebai control medicinal material.

[0069] Comparative proportion pharmacopoeia method

[0070] Take 4g of this product, grind it into powder, add 20ml of n-hexane, ultrasonically treat it for 20 minutes, filter it, evaporate the filtrate, add 1ml of n-hexane to the residue to dissolve it, and use it as the test solution. Take another 4g of Xiebai as a reference medicinal material, and prepare a reference medicinal solution in the same way. According to the thin layer chromatography method (General Rule 0502), take 10μl of each of the above two solutions, spot them on the same silica gel G thin layer plate, use n-hexane-ethyl acetate (10:1) as the developing agent, develop, take out, dry, spray with 10% sulfuric acid ethanol solution, heat at 105℃ until the spots are clearly colored, and examine under ultraviolet light (365nm). The results show that ( Figure 8), if the pharmacopoeia method is used directly, there will be problems such as few spots, unclearness, and poor separation. Among them, 1: Xiebai Formula Granules (20090049); 2: Xiebai Formula Granules (20090059); 3: Xiebai Formula Granules (20090069); S: Xiebai control medicinal material.

Claims

1. A thin layer identification method for Xiebai, characterized in that: The following steps are involved: (1) Prepare the test solution: take the test sample powder, add methanol, ultrasonically treat, filter, evaporate the filtrate to dryness, dissolve the residue in water, shake and extract with a saturated n-butanol solution with water, combine the n-butanol solution, wash with an ammonia test solution, discard the ammonia test solution, wash with a saturated n-butanol aqueous solution, discard the water solution, evaporate the n-butanol solution to dryness, dissolve the residue in methanol, and use it as the test sample solution; (2) Preparation of Xiebai control solution: Take Xiebai control medicinal material, add water, heat to reflux, cool, filter, concentrate the filtrate to near dryness, add methanol to the residue, ultrasonicate, filter, evaporate the filtrate to dryness, dissolve the residue in water, shake and extract with a saturated n-butanol solution, combine the n-butanol solution, wash with ammonia test solution, discard the ammonia test solution, wash with a saturated n-butanol aqueous solution, discard the water solution, evaporate the n-butanol solution to dryness, dissolve the residue in methanol, and use it as the control medicinal material solution; (3) Spot the test sample solution and the Xiebai control solution on the same thin layer plate, develop with chloroform-ethyl acetate-methanol-water as the developing solvent, take out, dry, spray with 10% sulfuric acid ethanol solution, heat at 105°C until the spots are clearly colored, and examine under sunlight and ultraviolet light respectively; (4) When a main spot or a fluorescent main spot of the same color appears in the chromatogram of the test sample at the corresponding position in the chromatogram of the reference medicinal material, the test sample is Xiebai.

2. The method according to claim 1, characterized in that: The sample volume of the test sample in step (3) is 5 to 15 μl.

3. The method according to claim 1, characterized in that: The spotting volume of the Xiebai control solution in step (3) is 5 to 15 μl.

4. The method according to claim 1, characterized in that: The development temperature in step (3) is 10-40°C.

5. The method according to claim 1, characterized in that: The humidity of the development in step (3) is 18% to 88%.

6. A method for distinguishing Xiebai from counterfeit products, characterized in that: The following steps are involved: (1) preparing a test solution and a control solution according to the method of claim 1; (2) Spot the test sample solution and the Xiebai control solution on the same thin layer plate, develop with chloroform-ethyl acetate-methanol-water as the developing solvent, take out, dry, spray with 10% sulfuric acid ethanol solution, heat at 105℃ until the spots are clearly colored, and examine under sunlight and ultraviolet light respectively; (3) When the main spot or fluorescent main spot of the same color appears at the corresponding position in the chromatogram of the test sample and the control medicinal material, the test sample is Xiebai. Otherwise, it is a counterfeit.

7. The method according to claim 6, characterized in that: The sample volume of the test sample in step (2) is 5 to 15 μl.

8. The method according to claim 1, characterized in that: The spotting volume of the Xiebai control solution in step (2) is 5 to 15 μl.

9. The method according to claim 1, characterized in that: The development temperature in step (2) is 10-40°C.

10. The method according to claim 1, characterized in that: The humidity of the development in step (2) is 18% to 88%.

Citation Information

Patent Citations

  • Thin-layer identification method for allium macrostemon test sample

    CN113759066A

  • Treatment method of water-soluble components in allium macrostemon, thin-layer identification method and application of developing solvent

    CN117288842A

Cited By

  • Method for identifying different allium macrostemon bases and true and false products in allium macrostemon medicine including formula granules and application of different allium macrostemon bases and true and false products in allium macrostemon medicine

    CN119959446A

  • A method for identifying different Allium macrostemon origins and genuine and counterfeit products in Allium macrostemon medicinal materials, including formulated granules, and its application.

    CN119959446B